DK127487A - Substituerede thiazoler og oxazoler, laegemidler indeholdende disse forbindelser samt fremgangsmaade til deres fremstilling - Google Patents
Substituerede thiazoler og oxazoler, laegemidler indeholdende disse forbindelser samt fremgangsmaade til deres fremstillingInfo
- Publication number
- DK127487A DK127487A DK127487A DK127487A DK127487A DK 127487 A DK127487 A DK 127487A DK 127487 A DK127487 A DK 127487A DK 127487 A DK127487 A DK 127487A DK 127487 A DK127487 A DK 127487A
- Authority
- DK
- Denmark
- Prior art keywords
- oxazoles
- procedures
- compounds
- preparation
- pharmaceuticals containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3608290 | 1986-03-13 | ||
DE19863608290 DE3608290A1 (de) | 1986-03-13 | 1986-03-13 | Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE19863621775 DE3621775A1 (de) | 1986-03-13 | 1986-06-28 | Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE3621775 | 1986-06-28 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK127487D0 DK127487D0 (da) | 1987-03-12 |
DK127487A true DK127487A (da) | 1987-09-14 |
DK168991B1 DK168991B1 (da) | 1994-07-25 |
Family
ID=25841907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK127487A DK168991B1 (da) | 1986-03-13 | 1987-03-12 | Substituerede thiazoler og oxazoler, lægemiddel indeholdende en sådan forbindelse, anvendelse af en sådan forbindelse til fremstilling af et lægemiddel, fremgangsmåde til fremstilling af lægemidlet og fremgangsmåde til fremstilling af forbindelserne, samt substituerede thiazoler og oxazoler med mellemproduktanvendelse |
Country Status (19)
Country | Link |
---|---|
US (2) | US5457205A (da) |
EP (1) | EP0239815B1 (da) |
JP (1) | JPH0784446B2 (da) |
KR (1) | KR870008876A (da) |
CA (1) | CA1296002C (da) |
DE (2) | DE3621775A1 (da) |
DK (1) | DK168991B1 (da) |
ES (1) | ES2040215T3 (da) |
FI (1) | FI87777C (da) |
GR (1) | GR3002839T3 (da) |
HK (1) | HK106494A (da) |
HU (1) | HU196974B (da) |
IE (1) | IE59800B1 (da) |
IL (1) | IL81874A (da) |
MX (1) | MX9202818A (da) |
NO (1) | NO172849C (da) |
PH (1) | PH23996A (da) |
PL (1) | PL154772B1 (da) |
PT (1) | PT84462B (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3805382A1 (de) * | 1988-02-20 | 1989-08-31 | Boehringer Ingelheim Vetmed | Verwendung von thiazolen zur leistungssteigerung bei tieren |
JP3003148B2 (ja) * | 1989-01-05 | 2000-01-24 | 藤沢薬品工業株式会社 | チアゾール化合物、その製造法およびそれを含有する医薬組成物 |
US5576442A (en) * | 1991-07-22 | 1996-11-19 | Pfizer Inc. | Process and chiral intermediates for thiazole antidiabetics |
AU7084294A (en) * | 1993-07-14 | 1995-02-13 | Taisho Pharmaceutical Co., Ltd. | 5-acetylthiazoline oxime derivative |
US6472387B1 (en) | 1996-10-07 | 2002-10-29 | Eli Lilly And Company | Methods of using compounds as neuro-protective agents |
PT971709E (pt) | 1996-10-07 | 2003-09-30 | Lilly Co Eli | Novos compostos uteis como agentes neuro-protectores |
US6121288A (en) * | 1996-11-08 | 2000-09-19 | Nippon Chemiphar Co., Ltd. | Visceral fat lowering agent |
IL135433A0 (en) | 1997-10-06 | 2001-05-20 | Lilly Co Eli | Novel compounds useful as neuro-protective agents |
US5972099A (en) * | 1997-12-17 | 1999-10-26 | Bayer Corporation | Process for preparing organic pigment compositions |
US6121300A (en) * | 1998-11-10 | 2000-09-19 | Wagle; Dilip R. | Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
ES2234929T3 (es) * | 2000-11-28 | 2005-07-01 | Smithkline Beecham Plc | Derivados de morfolina como antagonistas de los receptores de orexina. |
CN101912380A (zh) * | 2003-04-15 | 2010-12-15 | 维尔斯达医疗公司 | 用于治疗代谢紊乱的化合物 |
JP4697973B2 (ja) | 2003-04-22 | 2011-06-08 | ウェルスタット セラピューティクス コーポレイション | 代謝障害の処置のための化合物 |
GB0324654D0 (en) * | 2003-10-22 | 2003-11-26 | Glaxo Group Ltd | Medicinal compounds |
TW200526588A (en) * | 2003-11-17 | 2005-08-16 | Smithkline Beecham Corp | Chemical compounds |
JP6063948B2 (ja) * | 2011-10-27 | 2017-01-18 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | ベータ3アゴニストおよび中間体を製造するプロセス |
US10791890B2 (en) | 2018-03-27 | 2020-10-06 | Omachron Intellectual Property Inc. | Surface cleaning apparatus |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3225042A (en) * | 1962-07-31 | 1965-12-21 | Lilly Co Eli | Hydroxymorpholines |
US3514465A (en) * | 1966-12-30 | 1970-05-26 | Degussa | Certain thiazolyl- and pyridinylaminoketones |
LU69079A1 (da) * | 1973-12-27 | 1975-08-20 | ||
DD144050A5 (de) * | 1978-06-05 | 1980-09-24 | Ciba Geigy Ag | Verfahren zur herstellung von n-alkylierten aminoalkoholen |
IE50355B1 (en) * | 1979-10-20 | 1986-04-02 | Wyeth John & Brother Ltd | Morpholine derivatives |
GB8418657D0 (en) * | 1984-07-21 | 1984-08-22 | Beecham Group Plc | Compounds |
US4826990A (en) * | 1987-09-30 | 1989-05-02 | American Home Products Corporation | 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents |
-
1986
- 1986-06-28 DE DE19863621775 patent/DE3621775A1/de not_active Ceased
-
1987
- 1987-03-03 ES ES198787102995T patent/ES2040215T3/es not_active Expired - Lifetime
- 1987-03-03 EP EP87102995A patent/EP0239815B1/de not_active Expired - Lifetime
- 1987-03-03 DE DE8787102995T patent/DE3771541D1/de not_active Expired - Fee Related
- 1987-03-10 PL PL1987264545A patent/PL154772B1/pl unknown
- 1987-03-11 FI FI871052A patent/FI87777C/fi not_active IP Right Cessation
- 1987-03-11 CA CA000531681A patent/CA1296002C/en not_active Expired - Lifetime
- 1987-03-12 DK DK127487A patent/DK168991B1/da active
- 1987-03-12 IE IE64487A patent/IE59800B1/en not_active IP Right Cessation
- 1987-03-12 IL IL81874A patent/IL81874A/xx not_active IP Right Cessation
- 1987-03-12 HU HU871084A patent/HU196974B/hu not_active IP Right Cessation
- 1987-03-12 PT PT84462A patent/PT84462B/pt not_active IP Right Cessation
- 1987-03-12 NO NO871028A patent/NO172849C/no unknown
- 1987-03-12 JP JP62055477A patent/JPH0784446B2/ja not_active Expired - Lifetime
- 1987-03-13 PH PH35027A patent/PH23996A/en unknown
- 1987-03-13 KR KR870002258A patent/KR870008876A/ko not_active Application Discontinuation
-
1991
- 1991-10-03 GR GR91401473T patent/GR3002839T3/el unknown
-
1992
- 1992-06-12 MX MX9202818A patent/MX9202818A/es unknown
-
1993
- 1993-03-12 US US08/030,744 patent/US5457205A/en not_active Expired - Fee Related
-
1994
- 1994-10-06 HK HK106494A patent/HK106494A/xx not_active IP Right Cessation
-
1995
- 1995-05-24 US US08/449,174 patent/US5604225A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPS62226971A (ja) | 1987-10-05 |
IL81874A (en) | 1991-01-31 |
NO172849C (no) | 1993-09-15 |
ES2040215T3 (es) | 1993-10-16 |
DE3771541D1 (de) | 1991-08-29 |
PT84462A (de) | 1987-04-01 |
NO871028L (no) | 1987-09-14 |
GR3002839T3 (en) | 1993-01-25 |
PL154772B1 (en) | 1991-09-30 |
NO871028D0 (no) | 1987-03-12 |
PT84462B (pt) | 1989-10-04 |
MX9202818A (es) | 1992-06-30 |
DE3621775A1 (de) | 1988-01-07 |
FI87777C (fi) | 1993-02-25 |
DK168991B1 (da) | 1994-07-25 |
KR870008876A (ko) | 1987-10-21 |
NO172849B (no) | 1993-06-07 |
FI871052A (fi) | 1987-09-14 |
HU196974B (en) | 1989-02-28 |
CA1296002C (en) | 1992-02-18 |
EP0239815B1 (de) | 1991-07-24 |
IL81874A0 (en) | 1987-10-20 |
PL264545A1 (en) | 1988-07-21 |
IE870644L (en) | 1987-09-13 |
HK106494A (en) | 1994-10-14 |
DK127487D0 (da) | 1987-03-12 |
FI87777B (fi) | 1992-11-13 |
PH23996A (en) | 1990-02-09 |
US5604225A (en) | 1997-02-18 |
FI871052A0 (fi) | 1987-03-11 |
HUT44246A (en) | 1988-02-29 |
EP0239815A1 (de) | 1987-10-07 |
JPH0784446B2 (ja) | 1995-09-13 |
US5457205A (en) | 1995-10-10 |
IE59800B1 (en) | 1994-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK231687A (da) | Heterocykliske forbindelser, deres fremstilling og anvendelse, samt laegemidler indeholdende disse forbindelser | |
DK158587A (da) | Thiazepinforbindelser, fremgangsmaader til fremstilling deraf samt farmaceutiske, praeparater, der indeholder disse forbindelser | |
DK209585A (da) | Pyrrolobenzimidazoler, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser samt mellemprodukter | |
DK362787D0 (da) | Benzensulfonamido-indanylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling | |
DK393482A (da) | Urinstofderivater, fremgangsmaade til fremstilling heraf og medikamenter indeholdende disse forbindelser samt deres anvendelse | |
DK164868C (da) | Imidazooe4,5-baaquinolin-2-on-derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse | |
DK163991C (da) | Dichloranilinderivater, fremgangsmaade til fremstilling af disse, samt farmaceutiske praeparater indeholdende derivaterne | |
DK127487A (da) | Substituerede thiazoler og oxazoler, laegemidler indeholdende disse forbindelser samt fremgangsmaade til deres fremstilling | |
DK219387A (da) | Aminothiazol- og aminooxazolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
DK451686A (da) | Arylmethylazoler og deres salte, fremgangsmaade til fremstilling deraf, midler indeholdende disse forbindelser samt deres anvendelse | |
DK408186D0 (da) | Podophyllotoxin og derivater deraf, fremgangsmaader til deres fremstilling og anvendelse samt farmaceutiske praeparater indeholdende forbindelserne | |
DK165367C (da) | Imidazolylalkylguanidinderivater, fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse forbindelser | |
DK486789D0 (da) | Benzoxazolinonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
DK457787A (da) | Sulfonamidoethylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling | |
DK572785D0 (da) | Imidazolderivater, laegemidler indeholdende disse forbindelser og fremgangsmaader til deres fremstilling | |
DK307085D0 (da) | 4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse | |
DK162984C (da) | 1-(2-ar-2-halogen-2-ethenyl)-1h-azoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse | |
DK191086D0 (da) | Benzisoselenazolonylderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse | |
DK553689D0 (da) | Phenyloxypropanolaminderivater, fremgangsmaade til fremstilling af saadanne forbindelser samt laegemiddel indeholdende disse | |
DK90189A (da) | Trisubstituerede aminer, fremgangsmaade til deres fremstilling samt laegemidler indeholdende disse forbindelser | |
NO871375D0 (no) | Bis-tertiaerbutylamino-substituerte 1,3,5-triazinderivater, fremgangsmaate til deres fremstilling, legemidler inneholdende disse forbindelser og deres anvendelse. | |
DK240984A (da) | 5-(4-chlor-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarboxylsyrer, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse | |
DK165978C (da) | 1-aminoethyl-1h-imidazolderivater, fremgangsmaader til fremstilling deraf samt antimykotiske midler indeholdende disse | |
DK501385D0 (da) | 1,3,4-thiadiazolderivater, fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse forbindelser | |
DK141784A (da) | Penemforbindelser, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse |